Integrated 'on-chip' optical coherence tomography (OCT) system for point of care imaging diagnostics
Integrated 'on-chip' optical coherence tomography (OCT) system for point of care imaging diagnostics
批准号:
EP/R014418/1
负责人:
Iain Crowe
金额:
$160.6万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The research context:Nepal is classified as one of the lowest income countries on the Development Assistance Committee (DAC) list and the general health of the population is considered to be poor by most measures, even in comparison with the rest of Asia. Access to healthcare is severely restricted, particularly in rural regions, which is undoubtedly a limiting factor to progress, generally. We have identified a specific unmet clinical need within Nepal that is fully aligned with this call for proposals; aided as it could be by the provision of affordable, point-of-care imaging diagnostics. There is an unusually high prevalence (up to 43%) of the population in Nepal suffering from chronic obstructive pulmonary disease (COPD) and this has been the number one cause of death (>9%) there in recent years. This is thought to arise principally as a result of poor indoor air quality, with the condition being even more acute in difficult to reach, both geographically and economically, rural regions. It is particularly high amongst women, which may be largely attributable to the deeply embedded culture of indoor cooking and heating with biomass fuelsAims and objectives:Our aim is to develop a low cost miniaturized, integrated chip-based optical coherence tomography (OCT) based diagnostic tool which will provide a transformative change to the level of sophistication that access to such clinical imaging technology can bring to bear on COPD diagnosis and therapy. The key advance will stem from transitioning the fibre based interferometer at the heart of commercial OCT systems onto the silicon photonics chip, which will enable system complexity and cost reductions through manufacturing scalability. Silicon photonics is aptly suited to this because it is transparent at the target operating wavelength (1300nm) of most OCT systems and the required interferometer components have now all been demonstrated in isolation. Manufacturing of these sub-micron optical devices can be massively scaled at lower cost and to extremely high tolerances using the global passive fabrication infrastructure that has been built up around the telecommunications industry. In addition, many of these components have now also been realised in the silicon nitride (SiN) platform, extending capabilities down towards the visible range, which is particularly relevant to certain biomedical imaging regimes. We will develop SiN based interferometers in parallel with the silicon devices through wavelength scaled common optical circuit designs as proof of concept. Finally, we will take the ambitious step of developing a complete, fibre-less chip based solution by hybrid integration of miniature optical sources with the silicon/SiN based interferometers.Potential applications and benefits:The vision of a low complexity, low cost, miniature OCT system incorporated within existing bronchoscopy or catheter based medical devices that could be used along with commercially available data acquisition hardware and analytical software on a mobile platform is within reach. Such a system can provide the necessary access to a sophisticated imaging diagnostic tool that could displace basic spirometry and even fibre based bronchoscopy as the gold standard for early diagnosis of COPD. Its greatest benefit will be felt, initially, within remote regions of our partner LMIC country, Nepal where a high prevalence of the disease is exemplified and where access to such facilities is limited by both geography and economy. Improvements in resolution and speed for tissue imaging can also be expected to help improve our understanding of COPD progression in a fundamental way. For example the development and widespread adoption of the proposed OCT technology would generate population specific datasets of high quality for use by researchers and clinicians.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1063/5.0010795
发表时间:
2020-08
期刊:
Applied Physics Letters
影响因子:
4
作者:
[G. R. Goldberg;Daehyun Kim;Richard J. E. Taylor;D. Childs;P. Ivanov;N. Ozaki;K. Kennedy;K. Groom;Y. Harada;R. Hogg]
通讯作者:
G. R. Goldberg;Daehyun Kim;Richard J. E. Taylor;D. Childs;P. Ivanov;N. Ozaki;K. Kennedy;K. Groom;Y. Harada;R. Hogg
DOI:
10.1364/cleo_at.2020.jth2b.11
发表时间:
2020
期刊:
影响因子:
--
作者:
[Maharjan R]
通讯作者:
Maharjan R
Power and spectral characterization of photonic integrated circuit based axicon like lens
基于光子集成电路的类轴锥透镜的功率和光谱特性
DOI:
10.48550/arxiv.2008.05130
发表时间:
2020
期刊:
影响因子:
--
作者:
[Maharjan R]
通讯作者:
Maharjan R
Improved retention of phosphorus donors in germanium using a non-amorphizing fluorine co-implantation technique
使用非非晶化氟共注入技术改善了磷供体在锗中的保留
DOI:
10.1063/1.4999210
发表时间:
2018
期刊:
Journal of Applied Physics
影响因子:
3.2
作者:
[Monmeyran C]
通讯作者:
Monmeyran C
DOI:
10.1109/jstqe.2019.2938057
发表时间:
2020-03
期刊:
IEEE Journal of Selected Topics in Quantum Electronics
影响因子:
4.9
作者:
[R. Anthony;D. Hagan;Dylan Genuth-Okon;L. Martinez Maestro;I. Crowe;M. Halsall;A. Knights]
通讯作者:
R. Anthony;D. Hagan;Dylan Genuth-Okon;L. Martinez Maestro;I. Crowe;M. Halsall;A. Knights
共 7 条
国内基金
海外基金
登录
查看更多内容
CHIP泛素化修饰CIB1结合PLK2介导线粒体功能障碍重塑肺腺癌糖代谢调 控肿瘤细胞转移
-
批准号:2026JJ50309
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周燕武
-
依托单位:
CHIP通过泛素化修饰RIP3调控巨噬细胞
坏死性凋亡在角膜新生血管形成中的作
用
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:叶一明
-
依托单位:
Triptonide 通过 CHIP 介导的蛋白酶体途径清
除野生型IDH1 急性髓系白血病细胞的机制
研究
-
批准号:TGY24H080029
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨琳琳
-
依托单位:
TAT-CHIP 融合蛋白减轻脓毒症心功能障碍的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:吴森泉
-
依托单位:
维生素D受体通过CHIP/Sirt6信号通路抑制肠道成纤维细胞活化的机制研究
-
批准号:82300582
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:余梦丽
-
依托单位:
基于压力敏感肾单位微流控芯片的肾上皮细胞CAT1-mTOR通路在梗阻性肾损伤中的作用机制研究
-
批准号:82370678
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:林厚维
-
依托单位:
黄蒲通窍胶囊调控CHIP泛素-蛋白酶体途径降解异常tau蛋白治疗阿尔茨海默病作用机制研究
-
批准号:82374553
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:蔡标
-
依托单位:
Tet2缺失介导的不确定潜能的克隆性造血(CHIP)调控NLRP3/IL-1β在腹主动脉瘤发生发展中的作用和机制
-
批准号:82371594
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:孔祥骞
-
依托单位:
衰老相关蛋白CHIP调控IRP2的分子机制及在多巴胺能神经元退行性变中的作用
-
批准号:82301787
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:贾凤菊
-
依托单位:
PRDX4/FSHR/CHIP轴维护颗粒细胞内质网蛋白质稳态在延缓卵巢功能减退中的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:孟艳
-
依托单位: